TSX-V:CNVI - TSX Venture Exchange - CA2059531020 - Common Stock - Currency: CAD
TSX-V:CNVI (4/30/2025, 7:00:00 PM)
0.38
-0.01 (-2.56%)
The current stock price of CNVI.CA is 0.38 CAD. In the past month the price decreased by -30.91%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 207.28M | ||
MIR.CA | MEDMIRA INC | N/A | 72.04M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 43.36M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 36.47M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 35.66M | ||
ASG.CA | AURORA SPINE CORP | N/A | 27.80M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 21.44M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 21.20M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 9.09M | ||
VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 659.10K | ||
EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 300.85K |
Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
CONAVI MEDICAL CORP
76 Berkeley Street
TORONTO ONTARIO CA
Employees: 4
Company Website: https://titanmedicalinc.com/
Investor Relations: http://www.titanmedicalinc.com/investors/
Phone: 14165487522
The current stock price of CNVI.CA is 0.38 CAD. The price decreased by -2.56% in the last trading session.
The exchange symbol of CONAVI MEDICAL CORP is CNVI and it is listed on the TSX Venture Exchange exchange.
CNVI.CA stock is listed on the TSX Venture Exchange exchange.
CONAVI MEDICAL CORP (CNVI.CA) has a market capitalization of 16.82M CAD. This makes CNVI.CA a Nano Cap stock.
CONAVI MEDICAL CORP (CNVI.CA) currently has 4 employees.
CONAVI MEDICAL CORP (CNVI.CA) has a resistance level at 0.41. Check the full technical report for a detailed analysis of CNVI.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CNVI.CA does not pay a dividend.
CONAVI MEDICAL CORP (CNVI.CA) will report earnings on 2025-08-11.
CONAVI MEDICAL CORP (CNVI.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.09).
ChartMill assigns a fundamental rating of 2 / 10 to CNVI.CA. The financial health of CNVI.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months CNVI.CA reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS decreased by -2664.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -174.28% | ||
ROE | -397.22% | ||
Debt/Equity | 0.26 |
ChartMill assigns a Buy % Consensus number of 80% to CNVI.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.